HN Desk
The Central Drugs Standard Control Organisation (CDSCO) has issued a circular cautioning the public, healthcare professionals, pharmacists, retailers, and hospitals against the indiscriminate, repeated, or prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics, citing risks of chronic kidney disease, adverse drug reactions, and antimicrobial resistance.
Issued by Drugs Controller General (India) Dr. Rajeev Singh Raghuvanshi, the circular states that most NSAIDs fall under Schedule H of the Drugs Rules, 1945, while most antibiotics are listed under Schedule H1. These medicines must not be sold without a prescription from a Registered Medical Practitioner (RMP), and their labels must carry the prescribed warnings and conditions of sale.
The regulator said NSAIDs and antibiotics should be used only when clinically indicated, at the appropriate dose, and for the appropriate duration under medical supervision. It warned that self-medication, sharing prescribed antibiotics, or using leftover medicines can contribute to avoidable harm and antimicrobial resistance.
The circular specifically advises people with pre-existing kidney disease or other risk factors for renal impairment to inform their doctor before taking NSAIDs. It also urges patients to seek medical advice if pain, fever, or other symptoms persist or recur, rather than repeatedly taking painkillers or antibiotics on their own.
Healthcare professionals have been advised to prescribe NSAIDs only after considering a patient’s age, clinical condition, co-morbidities, other medicines, and kidney-related risk factors. For patients at higher risk of renal impairment, the CDSCO recommends using the lowest effective dose for the shortest appropriate duration.
For antibiotics, the regulator called for judicious prescribing based on the likely cause of infection, its site and severity, relevant microbiological tests where appropriate, and local resistance patterns. It cautioned against unnecessary combination therapy, incorrect dosing, inappropriate drug selection, and unnecessarily long treatment courses.
Pharmacists, retailers, and distributors have been directed to strictly comply with prescription requirements for Schedule H and H1 drugs and not to encourage or facilitate self-medication with antibiotics or prescription-only NSAIDs. Hospitals and healthcare institutions have been asked to strengthen rational prescribing, prescription review, patient counselling, and antimicrobial stewardship systems. State and Union Territory drugs control authorities have been requested to create awareness among healthcare professionals, pharmacists, retailers, and the public, while ensuring compliance with the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945.




